Efficacy of infliximab biosimilars in patients with Crohn's disease – Authors' reply

K.K. Jørgensen, K.E. Lundin, I.C. Olsen, T.K. Kvien, J. Jahnsen
January, 2017
Cite DOI
Type
2
Publication
The Lancet